We have a serious adherence problem. Each year, medication non-adherence contributes to 125,000 preventable deaths, 25% of all hospitalizations and 50% of treatment failures in the US alone; enter DTx (digital therapeutics) products. Digital therapeutics are evidence-based digital therapeutic interventions to prevent, manage, or treat a medical disorder or disease. They’ve already proven effective in improving adherence in a wide range of health conditions, including diabetes management, MSK physiotherapy and asthma.
Listen as Christopher explores the Digital Therapeutics product landscape to uncover the key design principles being commonly used to drive patient engagement and improve adherence to treatment plans. Using real life examples, he will unpack the various types of engagement tactics being commonly used, such as quantifying progress, community, and certified guidance, and he will explain how new technologies such as Voice AI and Digital Biomarkers are reducing the barriers of data entry by making active tracking more effective.
Chris Scales, Director of Strategy and Insight, Star
The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
Subscribe to our channel for more videos.
Follow us on Twitter: [ Ссылка ]
Visit us at www.lsxleaders.com
![](https://i.ytimg.com/vi/I9aIU8B2KME/mqdefault.jpg)